This is a news story, published by Guardian, that relates primarily to Madeleine Finlay news.
For more Madeleine Finlay news, you can click here:
more Madeleine Finlay newsFor more biology news, you can click here:
more biology newsFor more news from Guardian, you can click here:
more news from GuardianOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
urinary tract infection. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest UTIs news, many need antibiotics news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
urological biologyGuardian
•
72% Informative
Madeleine Finlay speaks to Dr Jennifer Rohn , head of the centre for urological biology at University College London , about how UTIs take hold, and the complexity surrounding their treatment.
It gets to the heart of the challenge of tackling antimicrobial resistance.
VR Score
78
Informative language
81
Neutral language
49
Article tone
informal
Language
English
Language complexity
58
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links